2021
DOI: 10.1089/crispr.2021.29130.kad
|View full text |Cite
|
Sign up to set email alerts
|

A Field Day for Gene-Edited Brassicas and Crop Improvement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…In Europe, there is currently no commercially viable NGT-Brassicaceae product. However, applications for field trials were filed in both the EU and the UK (Napier, 2021). All trials were carried out with plants modified with the CRISPR/Cas9 gene scissors (Table 1).…”
Section: Field Trials and Commercialisation Pipelinementioning
confidence: 99%
“…In Europe, there is currently no commercially viable NGT-Brassicaceae product. However, applications for field trials were filed in both the EU and the UK (Napier, 2021). All trials were carried out with plants modified with the CRISPR/Cas9 gene scissors (Table 1).…”
Section: Field Trials and Commercialisation Pipelinementioning
confidence: 99%
“…Wang et al also took two critical steps to validate their innovation and to demonstrate that this was more than just some nice bioengineering. Firstly, they carried out field trials of their genetically modified (GM) camelina to show that the crop performs well in the 'real world' -vital if the technology is to be scaled up, yet sadly lacking in the vast majority of such research 4 . These field trials proved successful and sufficiently high yielding.…”
mentioning
confidence: 99%